Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Raderer

Showing results (121-130 of 264) with videos related to

Pageof 27
Sort By:
Plos One|March 9, 2019
Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled studyDominik Berzaczy, Alexander R Haug, Markus Raderer, et al.
Blood|May 29, 2004
Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphomaHannes Kaufmann, Markus Raderer, Stefan Wöhrer, et al.
Journal of Cancer Research and Clinical Oncology|July 23, 2013
Rituximab, Ara-C, dexamethasone and oxaliplatin (R-ADOx) is effective for treatment of elderly patients with relapsed mantle cell lymphomaWolfgang Lamm, Johannes Drach, Barbara Kiesewetter, et al.
Blood|October 31, 2002
T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphomaBerthold Streubel, Andrea Lamprecht, Judith Dierlamm, et al.
The Oncologist|September 2, 2018
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin AnalogsBarbara Kiesewetter, Heying Duan, Wolfgang Lamm, et al.
Annals of Hematology|March 18, 2014
Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysisStefan Wöhrer, Barbara Kiesewetter, Julia Fischbach, et al.
Journal of Cancer Research and Clinical Oncology|August 22, 2016
Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric originSusann Stollberg, Daniel Kämmerer, Elisa Neubauer, et al.
Journal of Neuroendocrinology|July 24, 2023
Does the dose matter? Antiproliferative efficacy and toxicity of everolimus in patients with neuroendocrine tumors - Experiences from a tertiary referral centerBarbara Kiesewetter, Philipp Melhorn, Simon Macheiner, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2016
Erratum to: Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric originSusann Stollberg, Daniel Kaemmerer, Elisa Neubauer, et al.
Haematologica|February 22, 2008
Autoimmune thrombocytopenia in non-Hodgkin's lymphomasAlexander W Hauswirth, Cathrin Skrabs, Christian Schützinger, et al.
Pageof 27

Showing results (121-130 of 264) with videos related to

Sort By:
Pageof 27
Plos One|March 9, 2019
Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled studyDominik Berzaczy, Alexander R Haug, Markus Raderer, et al.
Blood|May 29, 2004
Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphomaHannes Kaufmann, Markus Raderer, Stefan Wöhrer, et al.
Journal of Cancer Research and Clinical Oncology|July 23, 2013
Rituximab, Ara-C, dexamethasone and oxaliplatin (R-ADOx) is effective for treatment of elderly patients with relapsed mantle cell lymphomaWolfgang Lamm, Johannes Drach, Barbara Kiesewetter, et al.
Blood|October 31, 2002
T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphomaBerthold Streubel, Andrea Lamprecht, Judith Dierlamm, et al.
The Oncologist|September 2, 2018
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin AnalogsBarbara Kiesewetter, Heying Duan, Wolfgang Lamm, et al.
Annals of Hematology|March 18, 2014
Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysisStefan Wöhrer, Barbara Kiesewetter, Julia Fischbach, et al.
Journal of Cancer Research and Clinical Oncology|August 22, 2016
Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric originSusann Stollberg, Daniel Kämmerer, Elisa Neubauer, et al.
Journal of Neuroendocrinology|July 24, 2023
Does the dose matter? Antiproliferative efficacy and toxicity of everolimus in patients with neuroendocrine tumors - Experiences from a tertiary referral centerBarbara Kiesewetter, Philipp Melhorn, Simon Macheiner, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2016
Erratum to: Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric originSusann Stollberg, Daniel Kaemmerer, Elisa Neubauer, et al.
Haematologica|February 22, 2008
Autoimmune thrombocytopenia in non-Hodgkin's lymphomasAlexander W Hauswirth, Cathrin Skrabs, Christian Schützinger, et al.
Pageof 27